• Dr David Eccleston - 'The Tox Talks (Chapter 8): Nuceiva/Jeuveau/Prabotulinumtoxin' #263

  • Aug 1 2024
  • Length: 1 hr and 35 mins
  • Podcast

Dr David Eccleston - 'The Tox Talks (Chapter 8): Nuceiva/Jeuveau/Prabotulinumtoxin' #263

  • Summary

  • Episode 263 hosts Dr David Eccleston, a Cosmetic Physician from Birmingham, UK

    David joins us for chapter 8 of our mini-series 'The Tox Talks'. In these episodes we feature expert injectors who have significant experience in using botulinum toxins. These episodes explore our guests experiences using particular brands, the evolution of their injecting techniques and we get special insights into the subtle nuances of getting the best out of toxins.

    In chapter 8 we learn about one of the newest toxin brands called Nuceiva (Prabotulinum Toxin Type A). Manufactured by Evolus and also known as Jeuveau in the USA, Nuceiva will formally launch in Australia this week.

    JOIN OUR NEW LISTENER WHATSAPP GROUP & SEND US YOUR COMMENTS, SUGGESTIONS OR JUST SAY HI!

    Click here to join

    PATREON:

    Join our Patreon for on demand injectable & business education. Once subscribed you'll be added to our WhatsApp Community for 24/7 global support & networking with over 300 other colleagues

    SUPPORT THE PODCAST:

    Click here if you enjoy listening to IA every week and would like to contribute to supporting the podcast

    CHECK OUT OUR SPECIAL IA OFFERS:

    Click here to browse all of our latest partner discounts & offers!

    CONTACT INFORMATION:

    Contact IA and other important links

    Subscribe to IA on Apple Podcasts

    Subscribe to IA on Spotify

    Follow Dr Jake on Instagram

    Follow David on Instagram

    APPLY TO BE A CORPORATE PARTNER OR GUEST ON IA

    Click here to apply

    Show more Show less
activate_WEBCRO358_DT_T2

What listeners say about Dr David Eccleston - 'The Tox Talks (Chapter 8): Nuceiva/Jeuveau/Prabotulinumtoxin' #263

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.